Connect with us

Cannabis News

Alabama Officials Approve Medical Marijuana Dispensary Licenses, Readying Program For Sales To Start In 2026

Published

on

“I’m absolutely delighted today that we’re on the verge of having a work programme.”

By Anna Barrett, Alabama Reflector

The Alabama Medical Cannabis Board on Thursday approved three dispensary licenses in what board members called a critical step. making medical cannabis available in Alabama Almost five years after the legislature enacted the program.

“We’ve waited a long time to get to this point where we can make a decision like this, and it’s monumental,” said board chairman Rex Vaughn. “It’s a milestone for us, so I’m excited we can get this far.”

GP6 Wellness, RJK Holdings and CCS will receive Alabama dispensary licenses within 28 days, as long as the companies pay a $40,000 licensing fee. A fourth license will be approved by the board in late January based on a recommendation from an administrative law judge, Vaughn said after the meeting.

Vaughn said several times at the meeting that the approval of the dispensary licenses is a milestone and will provide the care patients need and tax revenue for the state.

“It takes time to get through the system, but we should be seeing revenue by spring at the latest,” Vaughn said.

Alabama’s cannabis law, passed in 2021, allows registered doctors to prescribe cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s disease, PTSD, sickle cell anemia, chronic pain and terminal illnesses. Acceptable product forms are limited to tablets, tinctures, patches, oils, and gummies (peach flavor only), herbal raw materials and smoking forms are prohibited.

People suffering from the conditions must obtain a doctor’s authorization and enter the patient registry to purchase products at a pharmacy.

Lawsuits have also hindered access to medical cannabis. Some companies sued the commission for not issuing licenses, citing a discriminatory process. In another case there were five Parents sued the board over delays in accessing cannabiswhich was released in August.

As of Thursday, the commission has issued licenses to nine growers, four processors, four transporters and three dispensaries. There is also a patient on the registry, Vaughn said.

Vaughn could not provide a specific timeline for when the product will be available for purchase, but estimated spring 2026. Earlier this year, AMCC Executive Director John McMillan expressed hope to have medical cannabis available to patients by the end of 2025.

“We need to get our medical certified quickly. All of those things are being arranged as we speak right now, and we’ll see how the winter goes,” Vaughn said. “Hopefully all these things will be implemented fairly quickly.”

Sam Blakemore, a pharmacist and board member, said in an interview after the meeting that medical cannabis can help relieve symptoms without side effects such as nausea and vomiting.

“Everyone focuses on Delta-9, but there are over 120 chemicals in the plant that are able to provide this whole-body experience to allow patients to really get relief when they have nausea and vomiting and spasticity,” Blakemore said.

Blakemore primarily prescribes drugs for pediatric oncology patients. He brought his wife and two young children to the meeting to celebrate the approval of the licenses.

“I’m not going to say that cannabis is a cure, but the most important thing to get that right now is at least people, I call patients and in the state where I close them, they can get relief,” Blakemore said. “They can’t get relief from opioids. They can’t get relief from gabapentin. They might finally be able to try something.”

Supporters of medicinal cannabis attended the meeting on Thursday.

Amanda Taylor, a medical cannabis patient advocate, has been part of the commission’s process since 2021. He has multiple brain and spinal injuries.

“I am very happy today because we are on the point of having a work program,” he said in an interview after the meeting.

This story was first published by the Alabama Reflector.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis News

Striving for inclusivity in Caribbean cannabis market

Published

on

By











The government of Antigua and Barbuda has reiterated its intention to build a medical cannabis sector based on local empowerment, careful regulation and cultural respect. At a stakeholder dialogue organized by the Medicinal Cannabis Authority (MCA), officials presented a new roadmap for the development of medicinal cannabis on the island.

Addressing industry stakeholders, Attorney General Sir Steadroy Benjamin emphasized that the administration’s aim was to redirect the profits of this industry to people who have historically been shunned by foreign investors.

“I want to make it clear that my government (…) is fully committed to ensure that the economic benefits of this industry benefit the people of Antigua and Barbuda as a whole, and not just land investors,” he said, and to assure participants “that the pie is significant.”

This change comes as the authorities have acknowledged that previous economic initiatives in the country often concentrated profits in the hands of large operators. The government now wants to ensure that this trend is “ended”, with the new cannabis regulatory framework serving as a corrective model.

Read more at News Weed










Continue Reading

Cannabis News

Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds

Published

on

By

Only six percent of marijuana users approve of the Trump administration’s actions on cannabis policy so far, according to a new poll. Rumors abound that the president plans to direct federal rescheduling of cannabis.

The latest version of NuggMD and Marijuana Moment’s quarterly presidential approval tracking poll also found that 51 percent of respondents would support the current administration if marijuana were rescheduled or legalized.

Some President Donald Trump calls cannabis III. Despite the recent news that plans to reclassify the drug as Schedule I under the Controlled Substances Act are very positive, marijuana users’ support for the president’s marijuana “actions” declined in the last quarter.

1.6 percent of respondents said they “strongly approve” of the actions, 4.5 percent approve, a plurality of 38.4 percent are neutral, 26.1 percent disapprove and 29.5 percent strongly disapprove.

“Do you approve or disapprove of the presidential administration’s actions regarding cannabis?”
n: %
Strongly accept 7 1.6%
accept 20 4.5%
No opinion/Neutral 172 38.4%
Condemn 117 26.1%
Very disapproving 132 29.5%
448
Score (-50 to +50) -19,364
Clear Accept/Reject: -49.6%

However, the poll data also reinforced the idea that Trump could move the needle among cannabis-using voters by enacting key reforms, such as rescheduling or legalization.

It found that among respondents, 51 percent said they would change their level of support for the president if he took action on these reform proposals.

1.5 percent said they would support it less, while 47.5 percent said their opinion would not change.

“If the Trump administration were to reschedule or legalize cannabis, would that change your level of support?”
n: %
I would accept much more 172 38.4%
I could tolerate a bit more 56 12.5%
No change 213 47.5%
I would accept less 2 0.4%
I would accept much less 5 1.1%
448
Score (-50 to +50): 21,652
Clear Accept/Reject: 49.3%

“I find these data to be evidence that the White House needs to take tangible action on cannabis reprogramming to capture the clear political benefit of the public we poll, cannabis consumers who participate in state legal and regulated markets,” said Andrew Graham, chief communications officer for Nugg MD, Marijuana Moment.

“The trial balloon about the imminence of the overhaul is not going to cut it,” he said, adding that he doesn’t believe an executive leading the move to Schedule III “resolves the many problems with how federal law treats cannabis, a legal substance in many states.”

However, “I think it would benefit the industry and increase access, and consumers of cannabis would notice,” Graham said.

The latest quarterly poll found Trump’s overall approval rating among marijuana users down, from 11 percent in the previous quarter to around six percent this quarter.

The survey — which interviewed 448 cannabis users living in states with legal markets and has a margin of error of ±4.63 percentage points — was conducted before the president announced plans to move forward with the reorganization process initiated by the Biden administration, with deadlines for action ranging from Monday to early next year.

Trump confirmed Monday when asked by a reporter “very strongly” considering rescheduling cannabisHe said the reform “brings in enormous amounts of research that can’t be done if you don’t reclassify.”

Amid rumors of a reconsideration, top Democrats in Congress have complained that the reform would not go far enough, including Sen. Ron Wyden (D-OR) who called the move only a tentative one. president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval rating.

Meanwhile, it is an important organization in the drug testing industry Amid ‘sounding the alarm’ reports Trump may soon end marijuana reregulation proposalthat the reform would have “catastrophic consequences for the safety of US workers and the transportation sector.”

Cannabis industry players are hopeful that reform will be passed as soon as possible, but opponents — including the National Drug and Alcohol Screening Association (NDASA) and Smart Approaches to Marijuana (SAM) — are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marihuana Moment that no action has been taken so far.

They have been bipartisan members of Congress weighing a possible decision to reorganize last week—Democrats like Rep. Alex Ocasio-Cortez (D-NY) call the reform a “no” and others like Rep. Andy Harris (R-MD) have pushed back against the proposal.

Trump said this in mid-August he would make the reorganization decision in a week. But despite that timeline and increasing rumors, a White House spokesman told Marijuana Moment last week that “no final decision has been made on rescheduling marijuana.”

The Washington Post reported Thursday afternoon that Trump planned to issue an executive order to federal agencies to move ahead with cannabis rescheduling.

The outlet also said the president met with marijuana industry executives Robert F. Kennedy Jr. earlier this week in the Oval Office. with Secretary of Health and Human Services and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump called Johnson, the House Speaker, who opposed the rescheduling of cannabis,

If the administration ultimately enacts the rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition half a century ago, when it was banned under Article III. With a reclassification, marijuana has medical value and a lower abuse potential compared to Schedule I drugs like heroin.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Trump endorsed the rescheduling — as well as an initiative to legalize access to industrial banking and adult use in Florida — on the campaign trail. The president had been silent on the issue since taking office for a second term, until a meeting in August where, in response to a reporter’s question, he announced that the administration would decide to reschedule in a few weeks.

The possibility of an immediate rescheduling announcement comes a few weeks later the president signed a major spending bill that would effectively ban most consumer hemp productsdrawing criticism from hemp industry players who say the policy change would wipe out the market.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

What does the upcoming Virginia market have in store for its workers?

Published

on

By











A union and a marijuana justice nonprofit are fighting for worker protections and fairness for small operations as the multibillion-dollar industry moves closer to coming online in Virginia.
Retail cannabis sales in Virginia could begin next November, but debate continues over how to set up the market in a way that’s fair to workers and small businesses.

A committee of state lawmakers met earlier this month to discuss the details of how to establish and regulate a retail cannabis market in Virginia. The debate has been going on for years and Republican Gov. Glenn Youngkin after a deadline blocked Virginia’s entry into an industry that last year had more than $30 billion in sales.

Democratic Gov.-elect Abigail Spanberger has said she supports the creation of a legalized retail market, so it’s likely to happen on her watch. Virginia already has medicinal cannabis and it is legal to possess an ounce for personal use. But unlike neighboring Maryland, it’s still illegal to buy and sell cannabis, for now.

Virginia lawmakers are developing legislation to establish a retail cannabis market in Virginia. They are balancing several goals, such as ensuring that small businesses are not pushed around by massive corporations; supporting local farmers in this ag-heavy situation; Righting wrongs perpetuated by racist accusations of the war on drugs and protecting public safety.

Read more at Dogwood










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media